trending Market Intelligence /marketintelligence/en/news-insights/trending/fsywvkbumtmbfpd0kub-kq2 content esgSubNav
In This List

Humanigen appoints director

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Humanigen appoints director

Humanigen Inc. appointed Robert Savage as a director.

Savage most recently served on the boards of Depomed Inc. and The Medicines Co. He is currently the president, CEO and chairman of Strategic Imagery LLC.

Brisbane, Calif.-based Humanigen is a biopharmaceutical company, focusing on developing medicines for patients with neglected and rare diseases with a focus on pediatric conditions in the U.S.